A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...

As prevalence of CVDs continues to increase, the AHA and AMA have developed the Target BP initiative to improve blood ...

In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this ...

Chinese scientists have found a common hypertension drug could prove potent in treating a rare but highly invasive brain ...

The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.

Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair ...

On an overcast Tuesday in December, Michael Hale stood before a group of students at the Portland Opportunities Industrial ...

Steve Van Wormer has published nearly 500 podcasts about pulmonary hypertension (PH) — more than perhaps anyone working in rare diseases.

Looking to boost your nutrition this year? The Mediterranean diet​ has topped the U.S. News & World Report's annual diet list​ again. Here's what to know.

PAH, or pulmonary hypertension, can leave someone breathless even after a short walk, but better drug combinations have ...

Glaucoma, the leading cause of blindness, is often marked by loss of retinal ganglion cells (RGCs). Necroptosis, a form of ...